Skip to Main Content

Issues

ISSN 0143-5221
EISSN 1470-8736

Review Articles

Clin Sci (Lond) (2018) 132 (1): 43–67.
Clin Sci (Lond) (2018) 132 (1): 85–91.

Commentaries

Clin Sci (Lond) (2018) 132 (1): 33–36.
Clin Sci (Lond) (2018) 132 (1): 127–130.

Research Articles

Clin Sci (Lond) (2018) 132 (1): 1–16.
Clin Sci (Lond) (2018) 132 (1): 17–31.
Clin Sci (Lond) (2018) 132 (1): 69–83.
Clin Sci (Lond) (2018) 132 (1): 93–110.
Clin Sci (Lond) (2018) 132 (1): 111–125.
Clin Sci (Lond) (2018) 132 (1): 131–143.
Clin Sci (Lond) (2018) 132 (1): 145–156.
Clin Sci (Lond) (2018) 132 (1): 157–171.

Correspondence

Clin Sci (Lond) (2018) 132 (1): 37–38.
Clin Sci (Lond) (2018) 132 (1): 39–41.
  • Cover Image

    Cover Image

    issue cover
    Oleic-acid-treated HepG2 cells immunostained for PGC-1α (PPARγ co-activator-1 α). In Clinical Science volume 132, issue 1, the results of work by Bernardi et al. include reporting that the protein TRAIL (TNF-related apoptosis inducing ligand) increases the expression of PGC-1α in HepG2 cells cultured with oleic acid. Overall, the article points to a potential therapeutic role for TRAIL against impaired glucose tolerance and non-alcoholic fatty liver disease; for details see pages 69–83.
Close Modal
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close Modal
Close Modal